Gilead to buy cancer drugmaker Immunomedics in $21 billion deal This is a developing news story. Please check back for updates: https://www.cnbc.com/2020/09/13/gilead-to-buy-cancer-drugmaker-immunomedics-in-21-billion-deal.html Follow @CNBCnow for breaking news and real-time market updates Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel Digital Products Feedback Privacy Policy CNBC Events © 2020 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS
Post a Comment